annb0t
Top 20
Mayne Pharma Group Limited (ASX:MYX) shareholders should be happy to see the share price up 27% in the last quarter. But will that heal all the wounds inflicted over 5 years of declines? Unlikely. Five years have seen the share price descend precipitously, down a full 75%. The recent bounce might mean the long decline is over, but we are not confident. The fundamental business performance will ultimately determine if the turnaround can be sustained.
With the stock having lost 13% in the past we...
>>> Read more: Mayne Pharma Group (ASX:MYX shareholders incur further losses as stock declines 13% this week, taking five-year losses to 72%
With the stock having lost 13% in the past we...
>>> Read more: Mayne Pharma Group (ASX:MYX shareholders incur further losses as stock declines 13% this week, taking five-year losses to 72%
